Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mercury develops protein-kinase technology for treatment of type 2 diabetes

Nov. 27, 2007

New therapeutic agents for endocrine disorders disclosed in recent patents

Nov. 27, 2007

Diamyd enters agreement with National Institutes of Health for trial of Diamyd

Nov. 26, 2007

Ardana reports positive results from clinical trial of its testosterone cream

Nov. 26, 2007

Selective antagonists of the SST5 receptor identified at Roche

Nov. 26, 2007

GlaxoSmithKline acquires Reliant Pharmaceuticals for USD 1.65 billion

Nov. 23, 2007

New treatments for metabolic disorders reported in recent IRM and Schering patents

Nov. 23, 2007

Novo Nordisk reports positive results from phase II study of liraglutide for obesity

Nov. 23, 2007

Bone Medical initiates phase I/II clinical trial of oral CaPTHymone for osteoporosis

Nov. 23, 2007

Niacin/laropiprant combined with simvastatin improves dyslipidemia

Nov. 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...